Biogen partners with Quintiles to beef up its clinical development processes

|About: Biogen Inc. (BIIB)|By:, SA News Editor

The companies begin a 5-year strategic clinical development agreement to increase Biogen Idec's (BIIB) clinical trial efficiency. A dedicated Quintiles (Q) team will work on the design, planning and execution of Biogen's Phase 2, 3 and 4 clinical trials and a select number of Phase 1's.

Biogen will leverage Quintiles' technology and systems across its portfolio of products.

No financial terms are disclosed.